Gina Mazzariello
CIK: 0001913765
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Amylyx Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Sep 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct11 shares at avg. $33.34$366.74 - Sep 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct9.5K shares at avg. $32.46$309K - Aug 18, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Award(A)Direct21.3K shares- - Jul 10, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct15K shares at avg. $17.61$264K - Jul 9, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct15K shares at avg. $18.32$275K - Mar 5, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Award(A)Direct74.7K shares- - Mar 2, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct6.8K shares at avg. $14.52$99K - Feb 23, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct3.4K shares at avg. $14.14$48K - Feb 2, 2026AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct3.4K shares at avg. $14.65$51K - Sep 30, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct8.8K shares at avg. $14.58$129K - Aug 13, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct15K shares at avg. $8.34$125K - Aug 12, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct15K shares at avg. $8.07$121K - May 22, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Gift(G)Direct1K shares- - Mar 31, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct9.2K shares at avg. $3.48$32K - Mar 6, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Award(A)Direct63.9K shares- - Mar 3, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct1.6K shares at avg. $3.12$5K - Feb 24, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct4.2K shares at avg. $3.15$13K - Feb 3, 2025AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct3.7K shares at avg. $3.49$13K - Sep 30, 2024AMLX
Amylyx Pharmaceuticals, Inc.
Sale(S)Direct8.7K shares at avg. $3.20$28K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 11 | $33.34 | $367 | Direct |
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 9,525 | $32.46 | $309,140 | Direct |
| Aug 18, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Award(A) | 21,284 | - | $0 | Direct |
| Jul 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 15,000 | $17.61 | $264,122 | Direct |
| Jul 9, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 15,000 | $18.32 | $274,746 | Direct |
| Mar 5, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Award(A) | 74,660 | - | $0 | Direct |
| Mar 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 6,844 | $14.52 | $99,378 | Direct |
| Feb 23, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 3,419 | $14.14 | $48,352 | Direct |
| Feb 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 3,448 | $14.65 | $50,516 | Direct |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 8,828 | $14.58 | $128,669 | Direct |
| Aug 13, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 15,000 | $8.34 | $125,046 | Direct |
| Aug 12, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 15,000 | $8.07 | $121,102 | Direct |
| May 22, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Gift(G) | 1,000 | - | - | Direct |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 9,192 | $3.48 | $31,954 | Direct |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Award(A) | 63,851 | - | - | Direct |
| Mar 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 1,611 | $3.12 | $5,022 | Direct |
| Feb 24, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 4,169 | $3.15 | $13,145 | Direct |
| Feb 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 3,678 | $3.49 | $12,839 | Direct |
| Sep 30, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | Sale(S) | 8,709 | $3.20 | $27,840 | Direct |
1-19 of 19 transactions
About Mazzariello Gina
Mazzariello Gina (SEC CIK 0001913765) files insider reports with the SEC as Chief Legal Officer of Amylyx Pharmaceuticals, Inc. (AMLX).
Signal8 holds 16 ownership filings by Mazzariello Gina, all Form 4s, filed between Oct 2, 2024 and Sep 14, 2026. Those filings report 19 transactions, from Sep 30, 2024 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mazzariello Gina's filings is in CAMBRIDGE, MA.
Recent filings by Mazzariello Gina
- Sep 10, 2026: Open-market sales of AMLX shares (2 lines, Form 4, code S).
- Aug 18, 2026: Grant or award of AMLX shares (Form 4, code A).
- Jul 10, 2026: Open-market sale of AMLX shares (Form 4, code S).
- Jul 9, 2026: Open-market sale of AMLX shares (Form 4, code S).
- Mar 5, 2026: Grant or award of AMLX shares (Form 4, code A).
Other insiders filing for Amylyx Pharmaceuticals, Inc. (AMLX)
- MILNE GEORGE M JR, Director
- Bedrosian Camille L, Chief Medical Officer
- FRATES JAMES M, Chief Financial Officer
- Klee Justin B., Co-Chief Executive Officer
- Cohen Joshua B, Co-Chief Executive Officer
- Firestone Karen, Director